Clinical Trials Browser

OTHER × Neoplasms × Sunitinib × Clear all

NCT02693535 2026-04-02

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Phase 1 Completed

GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

NCT00330564 2024-06-27

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Phase 2 Terminated

15 enrolled 5 charts

Carcinoma, Renal Cell, Cysts, von Hippel-Lindau Disease, Neoplasms, Hemangioblastoma

NCT02925234 2024-01-24

DRUP

Phase 2 Recruiting

Neoplasms

NCT01636908 2021-04-15

ICK

Phase NA Completed

Neoplasms

NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Phase NA Unknown

Glioma, Neoplasms

NCT00463060 2018-07-18

Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

Phase 1/2 Completed

47 enrolled 18 charts

Neoplasms

NCT01108445 2018-01-16

ASPEN

Phase 2 Completed

131 enrolled 21 charts

Kidney Neoplasms, Neoplasms

NCT01784978 2017-10-02

SUNRISES

Phase 2 Terminated

Margins of Excision, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT00400114 2017-05-08

Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT01054911 2016-09-22

Evaluation of Patients With Bulky GIST Using Sunitinib

Phase NA Terminated

5 enrolled 4 charts

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT01215578 2015-04-30

NET

Phase 2 Terminated

EndocrineGastrointestinalNET

Adenocarcinoma, Adenoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Pancreatic Diseases, Pancreatic Neoplasms, Neuroectodermal Tumors, Neuroendocrine Tumors

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT00980213 2014-02-06

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

Carcinoma, Renal Cell, Neoplasms

NCT00402415 2013-12-18

Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy

Phase 1 Terminated

Neoplasm Metastasis, Neoplasms

NCT00510640 2013-02-28

THYSU

Phase 2 Completed

Neoplasms, Thyroid Neoplasms

NCT00434109 2012-09-14

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

Phase 2 Completed

39 enrolled 11 charts

Carcinoid Tumor, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Neuroendocrine Tumors

NCT01548170 2012-03-08

To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib

Phase 1 Completed

Neoplasms

NCT00673504 2011-12-01

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms